In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Rogaine first year sales trending at over $100 mil. based on IRI data through November.

This article was originally published in The Tan Sheet

Executive Summary

ROGAINE FIRST YEAR OTC SALES TRENDING AT OVER $100 MIL., according to data from Information Resources, Inc. Launched in April, the Rx-to-OTC switch product showed sales through November of $96.8 mil. in food, drug and mass merchandiser outlets, constituting an 86.8% dollar share of the hair regrowth market. Pharmacia & Upjohn has predicted that five-year OTC Rogaine sales will total $650 mil. ("The Tan Sheet" May 13, 1996, In Brief)





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts